Unravelling the Regulatory Roadmap for Allogeneic Products
Time: 2:00 pm
day: Day Two
Details:
• Recent guideline changes in Europe to inform on clinical trial design and data requirements
• How new cell and gene therapy comparability guidelines may impact process changes during development
• Global differences in data requirements for the transition from preclinical to clinical trials
